333PRibociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) who received prior chemotherapy (CT) for advanced disease: Preliminary subgroup results from the phase IIIb CompLEEment-1 trial. (23rd October 2018)

Record Type:
Journal Article
Title:
333PRibociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) who received prior chemotherapy (CT) for advanced disease: Preliminary subgroup results from the phase IIIb CompLEEment-1 trial. (23rd October 2018)
Main Title:
333PRibociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) who received prior chemotherapy (CT) for advanced disease: Preliminary subgroup results from the phase IIIb CompLEEment-1 trial
Authors:
Cardoso, F
Papazisis, K
De Laurentiis, M
Ring, A
Lu, J
Martín, M
Azim, H A
Zamagni, C
Zhou, K
Wu, J
Zarate, J P
Cottu, P H
Abstract:
Is Part Of:
Annals of oncology. Volume 29(2018)Supplement 8
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Issue Display:
Volume 29, Issue 8 (2018)
Year:
2018
Volume:
29
Issue:
8
Issue Sort Value:
2018-0029-0008-0000
Page Start:
Page End:
Publication Date:
2018-10-23
Subjects:
Oncology -- Periodicals
616.992
Journal URLs:
https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:
10.1093/annonc/mdy272.323 ↗
Languages:
English
ISSNs:
0923-7534
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
12268.xml